Cure8 research brief
Preneoplastic (adenomatous and serrated) polyps can be precursors to colorectal cancer, so knowing how common they are and what raises risk may affect surveillance planning for people with ulcerative colitis.
Adults with ulcerative colitis, gastroenterologists and clinicians who manage IBD surveillance, and researchers studying dysplasia risk in IBD.
This brief reports an abstract-style cross-sectional study of 240 patients with ulcerative colitis at a tertiary center that examined colonoscopy findings for adenomatous and serrated (preneoplastic) polyps.
The study found a 16.2% prevalence of these polyps and identified older age, older age at first colonoscopy, and higher BMI as factors associated with having polyps. Eleven of the 39 patients with polyps had recurrence on later colonoscopies (mean 47.5 months); no recurrence risk factors were identified.
The article is presented as an abstract (structured-content depth: abstract), so the summary is grounded in the source-provided abstract rather than a full peer-reviewed article text. The study appears to be retrospective and cross-sectional using colonoscopy data from a single tertiary center. This is not treatment guidance.
If you have UC, talk with your GI about what this type of finding means for your surveillance plan and whether factors like age or BMI change how frequently you need colonoscopy.
Structured-content depth: abstract — this summary is based on the article abstract supplied by the source. Single-center, retrospective design and limited extraction mean findings may not generalize. The abstract reports associations, not causal effects. The study reports lower prevalence than some general-population estimates but does not provide long-term cancer outcomes.
Review the original publication for the complete reporting, methods, and context.
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.
This study evaluated whether blood levels of LRG track endoscopic and clinical disease activity in people with suspected UC or Crohn’s disease, which could point to a noninvasive inflammation biomarker.
If confirmed, an endocytoscopic appearance that corresponds to a specific miRNA and chemokine pattern could help clinicians assess mucosal inflammation during colonoscopy and prioritize biopsies or treatment decisions...
Noninvasive monitoring matters for children with UC because endoscopy is burdensome. If ultrasound (and simple measures like bowel wall thickness) can reliably detect moderate-to-severe disease, families may avoid some...
